@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix ns0: <https://lod.nal.usda.gov/naltv#> .

<https://lod.nal.usda.gov/nalt>
  rdfs:label "NALT Full"@en ;
  a skos:ConceptScheme .

nalt:24723442_def
  rdf:value "Modelos empleados en las etapas iniciales de los ensayos clínicos para efectuar evaluaciones y pruebas antes de pasar a las etapas humanas de dichos ensayos."@es, "Preclinical animal models are used in the beginning stages of clincial trials for evaluation and testing before moving on to human stages of the clincial trials."@en ;
  dc:source "Based upon Everitt, J. I. (2015). The Future of Preclinical Animal Models in Pharmaceutical Discovery and Development: A Need to Bring In Cerebro to the In Vivo Discussions. Toxicologic Pathology, 43(1), 70–77. " ;
  a <https://lod.nal.usda.gov/naltv#Definition> .

nalt:24723442
  skos:prefLabel "modelos animales preclínicos"@es, "preclinical animal models"@en ;
  dc:created "2023-04-03"^^xsd:date ;
  a skos:Concept ;
  skos:inScheme <https://lod.nal.usda.gov/nalt>, <https://lod.nal.usda.gov/nalt-awic> ;
  ns0:marc001 "24723442" ;
  skos:definition nalt:24723442_def ;
  dc:modified "2024-05-04"^^xsd:date ;
  skos:broader nalt:9120 .

nalt:9120
  skos:prefLabel "modelos animales"@es, "animal models"@en ;
  a ns0:Topic, skos:Concept ;
  skos:narrower nalt:24723442 .